Table 6.
Endocrine evaluation in a patient with obesity
| Gland | Prevalence in obesity | When to assess | First diagnostic procedure | Other mandatory workup in obesity | Not recommended in obesity |
|---|---|---|---|---|---|
| Thyroid | Severe hypothyroidism is rare but subclinical hypothyroidism is common | Thyroid function should be tested in all patients with clinical suspicion of hypothyroidism, those having resistant obesity, and those undergoing procedures for weight loss | TSH | Free T4 and antibodies (anti-TPO) should be measured only if TSH is elevated | Routine FT3 in patients with elevated TSH; Routine ultrasound of the thyroid gland (irrespective of thyroid function) |
| Adrenal | Cushing’s disease or Cushing’s syndrome is rare | Central obesity; Hypertension; Classic striae Facial plethora; Proximal myopathy; Purpura |
1 mg ODST | 24-hr urine cortisol or late-night salivary cortisol in patients with positive 1 mg overnight dexamethasone suppression test; Imaging (find the cause/source) and ACTH in patients with confirmed hypercortisolism |
Routine testing for hypercortisolism |
| Drug-induced adrenal dysfunction (e.g., glucocorticoids) is common | Biochemical testing should be performed in patients with clinical suspicion of hypercortisolism; those undergoing bariatric surgery, or having psychiatric disorders | 8 am cortisol | Testing for hypercortisolism in patients using corticosteroids | ||
| Male gonad | Androgen deficiency is common | Severe obesity; Symptoms and signs of hypogonadism |
LH, FSH, fasting morning testosterone | Total and free testosterone (or calculated), SHBG in patients with clinical features of hypogonadism | Routine biochemical testing for hypogonadism unless key clinical symptoms or signs of hypogonadism |
| Female gonad | Androgen excess is common | Central obesity; Irregular menses; Hirsutism; Acanthosis nigricans chronic anovulation/infertility |
LH, FSH, estradiol, testosterone | Total testosterone, SHBG, Δ 4androstenedione, 17-hydroxyprogesterone and prolactin in patients with menstrual irregularities (assess in early follicular phase if menstrual cycle is predictable) | Routine testing for gonadal dysfunction |
| Clinical features of PCOS | Total testosterone, free T, Δ 4androstenedion, SHBG and blood glucose | Ovarian morphology | |||
| Pituitary | GH deficiency is rare | Hypothalamic or pituitary disease, pituitary or hypothalamic surgery or radiation therapy |
IGF1/GH using a dynamic test only in patients with suspected hypopituitarism | Routine testing for IGF1/GH |
|
| Hypopituitarism is rare | Suspicion of hypothalamic obesity; Surgery or radiotherapy in pituitary region |
FT4 TSH LH FSH (testosterone or estradiol); GH IGF-1 PRL; ACTH stimulation test; GH stimulation test |
|||
| Acquired hypothalamic obesity (hypothalamic lesions or, tumors) is rare | Severe hyperphagia; Possible multiple endocrine abnormalities |
Brain CT/MRI | |||
| Parathyroid | Pseudohypoparathyroidism type 1a (Albright hereditary osteodystrophy) is rare | Short stature, short fourth metacarpal bones, obesity, s.c. calcifications, developmental delay | PTH↑calcium↓phosphate ↑ | Routine testing for hyperparathyroidism or Vitamin D deficiency | |
| Syndromic obesity | Hypothalamic obesity associated with Genetic Syndromes is very rare | Hypogonadism (hypogonadism or hypergonadotropic) or variable gonadal function; dysmorphic syndrome, mental and grow retardation | Leptin (leptin resistance); genetic testing | Routine testing of hormones such as leptin and ghrelin in patients with suspicion of syndromic obesity |
Abbreviations: ACTH, Adrenocorticotropic hormone; FSH, Follicle-stimulating hormone; FT4, Free thyroxine; GH, Growth hormone; IGF, Insulin-like growth factor; LH, Luteinizing hormone; MC4R, Melanocortin receptor 4; ODST, Overnight dexamethasone suppression test; PCSK, Proprotein convertase subtilisin/kexin; PTH, Parathyroid hormone; TSH, Thyroid-stimulating hormone